Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03451084 |
| Title | A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Aslan Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| 1 Site | Louisville | Kentucky | 40241 | United States | Details | |
| 1 Site | Albury | New South Wales | Australia | Details | ||
| 3 Sites | Darlinghurst | New South Wales | Australia | Details | ||
| 1 Site | Waratah | New South Wales | Australia | Details | ||
| 1 Site | Douglas | Queensland | Australia | Details | ||
| 1 Site | Adelaide | South Australia | Australia | Details | ||
| 3 Sites | Melbourne | Victoria | Australia | Details | ||
| 3 Sites | Singapore | Singapore | Details |